Tonix Pharmaceuticals Holding (TNXP) EBT Margin (2022 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted EBT Margin of 303.48% for Q2 2026, up 48.07% on a QoQ basis from 584.34% in Q1 2026, and up 106554.0% year-over-year from N/an in Q2 2025.
Powered by 
Analysis
Tonix Pharmaceuticals Holding (TNXP) EBT Margin (2022 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding has reported EBT Margin for 5 years, with the latest figure at 303.48% in Q2 2026.
- On a quarterly basis, EBT Margin rose 106554.0% year-over-year to 303.48% in Q2 2026; TTM through Jun 2026 was 550.04%, a 28008.0% increase from a year earlier, with the FY2025 full-year figure at 928.1%, up 43819.0% from the prior year.
- EBT Margin was 303.48% for Q2 2026 at Tonix Pharmaceuticals Holding, up from 584.34% in the prior quarter.
- The five-year high for EBT Margin was 303.48% in Q2 2026, with the low at 3501.59% in Q2 2024.
- Average EBT Margin over 5 years is 937.09%, with a median of 797.28% recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: EBT Margin slumped 268324 bps in 2024, then soared 213257 bps in 2025.
- Over 5 years, EBT Margin stood at 797.28% in 2022, then rose by 11 bps to 706.09% in 2023, then retreated by 25 bps to 881.45% in 2024, then climbed by 1 bps to 870.91% in 2025, then soared by 65 bps to 303.48% in 2026.
- The last three EBT Margin figures came in at 303.48% (Q2 2026), 584.34% (Q1 2026), and 870.91% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 29.63% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -4.34% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 12.17% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 18.33% |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 44.89% |
| 10 | Tonix Pharmaceuticals Holding | 220.65 Mn | 220.65 Mn | 12.84 Mn | -303.48% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -303.48% |
| Mar 31, 2026 | -584.34% |
| Dec 31, 2025 | -870.91% |
| Sep 30, 2025 | -967.66% |
| Jun 30, 2025 | -1,369.02% |
| Mar 31, 2025 | -644.71% |
| Dec 31, 2024 | -881.45% |
| Sep 30, 2024 | -561.20% |
| Jun 30, 2024 | -3,501.59% |
| Mar 31, 2024 | -860.23% |
| Dec 31, 2023 | -706.09% |
| Sep 30, 2023 | -701.30% |
| Jun 30, 2023 | -818.34% |
| Sep 30, 2022 | -797.28% |
| Jun 30, 2022 | -488.70% |